secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGEN CORP (NEOG)
CIK:        0000711377
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0000950170-25-108900
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neogen announces board retirement of William Boehm, appointment of Avi Pelossof effective Oct 23/24
--------------------------------------------------------------------------------

- William T. Boehm to retire from Neogen's Board effective Oct 23, 2025; served since 2011, chairs Audit Committee, member of Compensation & Talent Management Committee.
- Avi Pelossof appointed to Board effective Oct 24, 2025 as Class II director; over 25 yrs in diagnostics market, most recently CEO of Immucor.
- Pelossof previously Global President, Infectious Disease at Alere Inc., building a $750M portfolio and launching FDA CLIA-waived point-of-care test (now Abbott's ID NOW).
- Pelossof will participate in Neogen's non-employee director compensation program as described in 2024 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/0000950170-25-108900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/neog-20250814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-108900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer